SCM
DCOY

Sio Capital Management’s Decoy Therapeutics DCOY Stock Holding History

Sio Capital Management’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-38
Closed -$671K – 81
2021
Q4 		$671K Hold
38
– – 0.2% 60
2021
Q3 		$1.38M Hold
38
– – 0.44% 49
2021
Q2 		$1.44M Sell
38
-49
-56% -$2.18M 0.36% 61
2021
Q1 		$4.62M Buy
87
+41
+89% +$2.35M 0.94% 37
2020
Q4 		$1.51M Buy
+46
New +$1.35M 0.31% 73

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $394M AUM 44.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LNWWM
Laird Norton Wetherby Wealth Management San Francisco, California $2.45B AUM

Sio Capital Management's DCOY Position: Q1 2022 in Review

Sio Capital Management sold out of Decoy Therapeutics (DCOY) in Q1 2022, closing a stake of 38 shares — an estimated $671K sold.

Sio Capital Management first reported a position in DCOY in Q4 2020 and held it in 5 quarters. The position peaked at $4.62M in Q1 2021. 15 funds tracked by Wall St. Rank hold DCOY as of Q1 2022.

  • Sio Capital Management reported no remaining Decoy Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Sio Capital Management sold 38 Decoy Therapeutics shares in Q1 2022, an estimated $671K.
  • Sio Capital Management first reported a position in Decoy Therapeutics in Q4 2020 and held it in 5 quarters.
  • Sio Capital Management's Decoy Therapeutics position peaked at $4.62M in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q1 2022.

Based on Sio Capital Management's 13F filing for Q1 2022, filed 16 May 2022.